Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03386513
Title Study of IMGN632 in Patients With Relapse/Refractory AML, BPDCN, ALL, Other CD123+ Hem Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

myeloproliferative neoplasm

hematologic cancer

chronic myeloid leukemia

aggressive NK-cell leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

IMGN632

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.